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Enzyme mechanismtrans-3-Chloroacrylic acid dehalogenase (CaaD) catalyzes the hydrolytic dehalogenation of trans-3-
haloacrylates to yield malonate semialdehyde by amechanism utilizing bPro-1, aArg-8, aArg-11, and
aGlu-52. These residues are implicated in a promiscuous hydratase activity where 2-oxo-3-pentyno-
ate is processed to acetopyruvate. The roles of three nearby residues (bAsn-39, aPhe-39, and aPhe-
50) are unexplored. Mutants were constructed at these positions (bN39A, aF39A, aF39T, aF50A and
aF50Y) and kinetic parameters determined along with those of the aR8K and aR11K mutants. Anal-
ysis indicates that aArg-8, aArg-11, and bAsn-39 are critical for dehalogenase activity whereas aArg-
11 and aPhe-50 are critical for hydratase activity. Docking studies suggest structural bases for these
observations.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
trans-3-Chloroacrylic acid dehalogenase (CaaD) is a heterohexa-
meric enzyme, which consists of small a-subunits (75 amino acids)
and b-subunits (70 amino acids), that converts the trans-isomers of
3-haloacrylates (1 and 2, Scheme 1) to malonate semialdehyde (5),
presumably through a halohydrin or enol intermediate (3 and 4,
respectively) [1,2]. CaaD is part of a catabolic pathway in Pseudo-
monas pavonaceae 170 for trans-1,3-dichloropropene, one of the
active ingredients in the agricultural nematocides Shell D–D and
Telone II [1,3,4]. The enzyme belongs to the tautomerase super-
family, a group of structurally homologous proteins characterized
by a conserved b–a–b structural motif and a catalytically impor-
tant amino-terminal proline [5,6].
In addition to the dehalogenation of the trans-3-haloacrylates,
CaaD catalyzes the hydration of 2-oxo-3-pentynoate (6, Scheme
2A) and 3-chloro- and 3-bromopropiolate (7 and 8 in Scheme 2B)
[7]. Upon hydration, the 3-halopropiolates are converted into po-
tent irreversible inhibitors of CaaD (an acyl halide or a ketene).
Inactivation of the enzyme results from the covalent modiﬁcationof bPro-1 (9, Scheme 2B). Hydration of 6 affords acetopyruvate
(10), which does not inactivate the enzyme. Although not physio-
logically relevant, these reactions are analogous to the hydrolytic
dehalogenation of 1 and 2, and their study has provided much in-
sight into the catalytic mechanism of CaaD [8].
For example, much knowledge has been gained from the crystal
structure of CaaD inactivated by 3-bromopropiolate (8 to 9,
Scheme 2B) [9]. The structure identiﬁed the active site and
suggested interactions that might be responsible for binding and
catalysis. In the structure of the inactivated enzyme (Fig. 1, PDB
entry 1S0Y), bPro-1 forms a covalent bond to the C-3 of a 3-oxopro-
panoate moiety, which is the adduct resulting from the enzyme-
catalyzed hydration of 8 (Scheme 2B). The carboxylate group
interacts with aArg-8 and aArg-11, and the remaining portion of
the adduct makes hydrophobic contacts with aPhe-50, aLeu-57,
and bIle-37. The carboxylate group of aGlu-52 appears ﬁxed by
the amide side chain of bAsn-39. aPhe-39 and aPhe-50 contribute
to the active site environment and form part of the active site wall.
Based on this arrangement of active site residues, a working
hypothesis for the mechanism of CaaD was formulated (Scheme 3).
The positions of aGlu-52 and bPro-1 in the active site, coupled with
the determination of a pKa value for bPro-1 of 9.3 [10], implicated
aGlu-52 as the general base catalyst that activates a water
molecule for attack at C-3 of 1 (or 2) and bPro-1 as the general acid
catalyst that provides a proton at C-2. Mutagenesis of these resi-
dues conﬁrmed their importance in the mechanism: there was
Scheme 1.
Scheme 2.
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activity for the bP1A mutant [1,9]. The two arginines (aArg-8 and
aArg-11) likely interact with the C-1 carboxylate group to align
the substrate and draw electron density away from C-3. Such an
interaction would make C-3 partially positively charged and
facilitate the Michael addition of water to generate the intermedi-
ate (3 or 4) by route A or B (Scheme 3). Replacing either residue by
alanine resulted in no detectable activity [1,9].
In this work, the contributions made by bAsn-39, aPhe-39, and
aPhe-50 to the activities of CaaD were assessed by mutagenesis
and docking studies. Accordingly, bAsn-39 was replaced with an
alanine, aPhe-39 was replaced with an alanine or a threonine,
and aPhe-50 was replaced with an alanine or a tyrosine. Subse-
quently, the kinetic parameters for each mutant-catalyzed reaction
(using 1, 2, or 6), as well as the pH-rate proﬁle of the aF50A-CaaD-
catalyzed reaction (using 2), were determined and compared to
those of the wild-type. In addition, the roles of aArg-8 andFig. 1. A close-up of one CaaD active site where the prolyl nitrogen is covalently
attached to the 3-oxopropanoate moiety (PDB entry 1S0Y). The residues comprising
the active site include bP1, bI37, bN39, aE52, aF390 , aL57, aF50, aR8, and aR11
(clockwise from bP1). The prime indicates that aF390 is from an adjacent subunit.
The core set of residues consists of bP1, aE52, aR8, and aR11. The residues under
investigation nearby the core set are bN39, aF390 , and aF50. A putative halide
binding pocket consists of bI37, aL57, aF390 , and aF50. The Figure was created with
PyMol [20].aArg-11 were examined in more detail by analyzing the kinetic
properties of both their alanine (with 6) and lysine mutants (with
1, 2, and 6). The results show that the interactions of aArg-8 and
aArg-11, or a similar cationic group such as lysine, with substrate
play an important role in both substrate binding and catalysis. The
interaction between the amide side chain of bAsn-39 and the car-
boxylate group of aGlu-52 is critical for positioning the aGlu-52
side chain in a favorable orientation for the activation of a water
molecule [11,12]. This activation of water is essential for the con-
version of the 3-haloacrylates 1 and 2, but not for the conversion
of the more electrophilic substrate 6. Finally, the results suggest
that aPhe-50 plays a much more signiﬁcant role in the CaaD reac-
tions than aPhe-39: aPhe-50 is likely critical for maintaining the
active site structural integrity and environment.
2. Materials and methods
2.1. Materials
Chemicals, biochemicals, buffers, solvents, and molecular biol-
ogy reagents were obtained from sources reported elsewhere
[13], or as indicated below. Literature procedures were used for
the synthesis of trans-3-bromoacrylic acid (2) and 2-oxo-3-pen-
tynoate (6) [7,14]. The sources for the components of Luria–Bertani
(LB) media as well as the enzymes and reagents used in the molec-
ular biology procedures are reported elsewhere [13,15]. The Ami-
con concentrator and the YM10 ultraﬁltration membranes were
obtained from Millipore Corp. (Billerica, MA). Pre-packed PD-10
Sephadex G-25 columns were purchased from Biosciences AB
(Uppsala, Sweden). Oligonucleotides for DNA ampliﬁcation and
sequencing were synthesized by Genosys (The Woodlands, TX).
Escherichia coli strain BL21-Gold(DE3) was obtained from Agilent
Technologies (Santa Clara, CA). The construction of the aR8A,
aR11A, aR11K, and aF39A mutants of CaaD are described else-
where [1,9].
2.2. General methods
Techniques for restriction enzyme digestion, ligation, transfor-
mation, and other standard molecular biology manipulations were
based on methods described elsewhere [15]. The PCR was carried
Scheme 3.
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Perkin Elmer Inc. (Wellesley, MA). DNA sequencing was performed
by the DNA Core Facility housed in the Institute for Cellular and
Molecular Biology (ICMB) at The University of Texas at Austin.
Mass spectral data was collected in the ICMB Protein and Metabo-
lite Facility. Samples were made up as previously described [7].
HPLC was performed on a Waters (Milford, MA) 501/510 system
using either a TSKgel DEAE-5PW (anion exchange) or a TSKgel Phe-
nyl-5PW (hydrophobic interaction) column (Tosoh Bioscience,
Montgomeryville, PA). Protein was analyzed by polyacrylamide
gel electrophoresis (PAGE) under denaturing conditions using so-
dium dodecyl sulfate (SDS) on gels containing 15% polyacrylamide
[16]. The gels were stained with Coomassie brilliant blue. Protein
concentrations were determined using the Waddell method [17].
The native molecular masses of CaaD and the mutant enzymes
were determined by gel ﬁltration chromatography on a Superose
12 column (Pharmacia Biotech AB, Uppsala, Sweden) using the
Waters 501/510 HPLC system. Kinetic data were obtained on a
Hewlett Packard 8452A or an Agilent 8453 Diode Array spectro-
photometer. The contents of the cuvettes were mixed using a
stir/add cuvette mixer (Bel-Art Products, Pequannock, NJ). The ki-
netic data were ﬁtted by nonlinear regression data analysis using
the Graﬁt program (Erithacus, Software Ltd., Horley, U.K.) obtained
from Sigma Chemical Co.
2.3. Construction of the CaaD mutants
The ﬁve CaaD mutants were constructed using the coding se-
quence for CaaD in pET44T2 as the template [1]. The aR8K mutant
was generated by the PCR using the primer 50-CACGGCATAT
GCCGATGATCTCTTGCGACATGAAATATGGGAGAACA-30, in which
the NdeI restriction site is shown in bold and the codon introducing
the mutation is underlined. This primer corresponds to the 50 end
of the wild-type coding sequence and was used in combination
with the reverse primer (primer R), 50-TTGCCCAAGCA-
GAGGGATCCCCTAGCT-30, in which the BamHI site is shown in bold.
The aF39T, aF50A, aF50Y, and bN39A mutants were generated by
overlap extension PCR [18]. The forward primer (primer F), 50-CAC-
GGCATATGCCGATGATCTCTTGCGAC-30, where the NdeI site is
shown in bold, and primer R (above) were used as the external
primers. The internal primers were as follows: 50-CCCCGCGAGAAC-
ATTACCTTTGTGATTCGG-30 and 50-CCGAATCACAAAGGTAATGTTC
TCGCGGGG-30 for the aF39T mutant; 50-ATTCGGGAGGGCAGCGG
GATCAACGCCGTTGAGCACGGC-30 and 50-GTTGATCCCGCTGCCCTCC
CGAAT-30 (primer A) for the aF50A mutant; 50-ATTCGGGAGGGCA
GCGGGATCAACTACGTTGAGCACGGC-30 and primer A for the
aF50Y mutant; and 50-TCCGACCCCAAGATCATCGCTGTGCTTCTGG
TG-30 and 50-GATGATCTTGGGGTCGGA-30 for the bN39A mutant.
The codon introducing the mutation is underlined in each primer.
The PCR reactions were carried out as described before, and theproducts were puriﬁed and cloned into the pET3a vector (Promega
Corp., Madison, WI) for expression of the mutant genes [1]. The
mutant genes were sequenced in order to verify that only the in-
tended changes had been introduced.
2.4. Expression, puriﬁcation, and characterization of the CaaD mutants
Expression and puriﬁcation of the CaaD mutants followed pre-
viously described procedures [1,7]. The puriﬁed enzymes were
analyzed by electrospray ionization mass spectrometry (ESI-MS).
The speciﬁc dehalogenase activities of the puriﬁed mutant en-
zymes were measured by incubating an appropriate amount of en-
zyme with 3 mL of 10 mM substrate (either 1 or 2) in 50 mM Tris–
SO4 buffer (pH 8.2) at 22 C. Halide release was monitored colori-
metrically as described before [1].
Kinetic assays were performed in 20 mMsodium phosphate buf-
fer (pH 9.0) at 22 C. The hydration of the trans-3-haloacrylates was
monitored by following the decrease in absorbance at 224 nm,
which corresponds to the hydration of 1 (e = 4900 M1 cm1) and
2 (e = 9700 M1 cm1) [7]. The hydration of 6wasmonitored by fol-
lowing acetopyruvate (10) production at 294 nm (e = 7000 M1 -
cm1) [7]. The pH dependence of the steady-state kinetic
parameters was measured in 20 mM sodium phosphate buffers,
with pH values ranging from 6.0 to 9.1, as previously described [10].
2.5. Docking studies
Docking studies were carried out using PyMOL with Autodock
Vina using 2 and 6 [19,20]. The strategy for the identiﬁcation of a
speciﬁc active site to use in the docking studies is described else-
where [12]. A CaaD active site with the 3-oxopropanoate moiety
covalently bound to bPro-1 (PDB entry 1S0Y) was selected as the
receptor site for docking studies. The atoms making up this adduct
were removed (in silico) before the docking experiments were car-
ried out. Docking trials were restricted to a 15 Å  15 Å  15 Å box
centered on the bPro-1 residue. The aR8K, aR11K, and aF50A mu-
tants of CaaD were individually designed in silico using Pymol
mutagenesis wizard [21]. The selected lysine rotomers had mini-
mal steric clashes and placed the positively charged amino group
nearest to the location observed for the guanidinium moieties of
the arginines in the wild type enzyme. The side chains of aE52,
aR8K and aR11K were made allowed to rotate freely in their indi-
vidual docking routines.
3. Results
3.1. Expression, puriﬁcation, and characterization of the CaaD mutants
Five single site-directed mutants (aR8K, aF39T, bN39A, aF50A,
and aF50Y) of CaaD, constructed in this work, and the four
Table 1
The observed and calculated monomer masses of wild-type CaaD and the active-site mutants.
Enzyme Observed mass of the a-subunita Calculated mass of the a-subunitb Observed mass of the b-subunita Calculated mass of the b-subunitb
CaaD 8343 8343 7506 7506
aR8A 8257 8258 7506 7506
aR8K 8314 8315 7505 7506
aR11A 8257 8258 7506 7506
aR11K 8313 8315 7505 7506
aF39A 8266 8267 7506 7506
aF39T 8297 8297 7505 7506
bN39A 8343 8343 7463 7463
aF50A 8266 8267 7505 7506
aF50Y 8359 8359 7506 7506
a The masses of the two subunits of each of the puriﬁed proteins were determined by electrospray ionization mass spectrometry [7]. A sample generates two major peaks in
the mass spectrum (after deconvolution) that correspond to the expected masses of the a- and b-subunits. The observed masses of the two peaks indicate that the amino-
terminal proline is not blocked in either subunit by the initiating methionine [22,23].
b The monomer masses are predicted from analysis of the translated amino acid sequences of the two genes coding for the a- and b-subunits of CaaD, but without the
initiating methionines.
Table 3
Kinetic parameters for the hydration of 1 and 2 by CaaD and the active-site mutants.a
Enzyme Substrate kcat (s1) Km (lM) Kcat/Km (M1 s1)
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were overexpressed in E. coli strain BL21(DE3), and puriﬁed
to > 95% homogeneity (as assessed by SDS–PAGE) using previously
described procedures [1,7,9]. DNA sequencing veriﬁed that only
the intended mutations had been introduced into each mutant
gene. The yields (in mg of homogeneous protein per liter of cell
culture) of the mutants varied from 5 to 25 mg.
The nine puriﬁed CaaD mutants were analyzed by ESI-MS and
gel ﬁltration chromatography. Mass spectral analysis of the indi-
vidual mutants showed two major peaks corresponding to the ex-
pected molecular masses of the a- and b-subunit of each mutant
(Table 1). This observation indicates that each mutant has under-
gone posttranslational processing to remove the initiating methio-
nine, resulting in a- and b-subunit with an N-terminal proline
[22,23]. In addition, the experimentally obtained molecular masses
of the puriﬁed mutant proteins conﬁrmed the presence of only the
intended amino acid substitutions. The mutant enzymes migrated
during gel ﬁltration chromatography comparably with the wild-
type enzyme, suggesting that gross conformational changes are
not likely present and that the characteristic heterohexameric qua-
ternary structure of the wild-type is present in the mutant en-
zymes [9].
3.2. Speciﬁc activities of the mutant enzymes
Speciﬁc activities for the nine mutant enzymes were measured
using saturating concentrations of the trans-3-haloacrylates andTable 2
Speciﬁc activities of wild-type CaaD and the active-site mutants.a
Enzyme Relative speciﬁc activity with 1 Relative speciﬁc activity with 2
CaaD 100 100
aR8A <0.01 <0.01
aR8K <0.01 <0.01
aR11A <0.01 <0.01
aR11K 19 26
aF39A 20 9
aF39T 31 25
bN39A 3 5
aF50A 25 5
aF50Y 233 225
a The speciﬁc activities were determined in 50 mM Tris–SO4 buffer (pH 8.2) at
22 C using saturating concentrations (i.e., 10 mM) of the indicated substrate [1].
Speciﬁc activity data are expressed relative to wild-type CaaD values, which are
deﬁned as 100 and are equivalent to 5080 and 12210 mU/mg for trans-3-chloro-
acrylate (1) and trans-3-bromoacrylate (2), respectively, where 1 mU/mg is deﬁned
as 1 nmol of halide produced per min per mg of protein. The error associated with
speciﬁc activity measurements is less than 10% of the value.expressed relative to the wild-type enzyme (Table 2) [1]. Changing
aArg-8 to an alanine or a lysine and changing aArg-11 to an alanine
(individually) essentially abolished catalytic activity of CaaD, con-
ﬁrming that these arginines are critical for enzymatic activity. The
aR11K mutant had partially restored catalytic activity compared
to the catalytically inactive aR11A mutant, suggesting that a posi-
tive charge at this position is important for activity. The aF39A,
aF39T, bN39A, and aF50A mutants are also able to process both
trans-3-haloacrylates, although with reduced activities (Table 2).
In contrast, changing aPhe-50 to a tyrosine results in an enzyme
with increased activity (2.3-fold) for both trans-3-haloacrylates.
3.3. Kinetic analysis of the mutant enzymes
The steady-state kinetic parameters for the hydratase activity of
the nine mutants were measured using the trans-3-haloacrylates
(1 and 2) (Table 3) and 2-oxo-3-pentynoate (6) (Table 4) as sub-
strates, and compared to the kinetic parameters for the hydratase
activity of wild-type CaaD. Changing aArg-8 to an alanine or a ly-
sine results in enzymes with no measurable activity using 1 or 2.
These mutants, however, are still able to process 6 to 10, although
at reduced catalytic efﬁciencies. For the aR8A mutation, there is aCaaDb 1 3.8 ± 0.1 31 ± 2 1.2  105
2 5.1 ± 0.1 37 ± 2 1.4  105
aR8A 1 <1.5  103 – –
2 <1.5  103 – –
aR8K 1 <1.5  103 – –
2 <1.5  103 – –
aR11A 1 <1.5  103 – –
2 <1.5  103 – –
aR11K 1 0.08 ± 0.004c – –
2 0.13 ± 0.01 247 ± 41 5.3  102
aF39A 1 0.46 ± 0.02 21 ± 3 2.2  104
2 0.44 ± 0.02 18 ± 3 2.4  104
aF39T 1 2.0 ± 0.1 97 ± 8 2.1  104
2 2.0 ± 0.1 44 ± 3 4.5  104
bN39A 1 <1.5  102 – –
2 <1.5  102 – –
aF50A 1 0.19 ± 0.03 280 ± 75 6.8  102
2 0.28 ± 0.03 170 ± 33 1.6  103
aF50Y 1 9.5 ± 0.5 120 ± 11 7.9  104
2 14.9 ± 1.1 118 ± 17 1.3  105
a The steady-state kinetic parameters were determined in 20 mM sodium phos-
phate buffer (pH 9.0) at 22 C. Errors are standard deviations.
b These kinetic parameters were taken from Wang et al. [7].
c Estimated based on the measured speciﬁc activity using 10 mM of 1 (Table 2).
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the kcat/Km is reduced 46-fold. For the aR8K mutation, there is a
12-fold decrease in kcat and a 7.3-fold decrease in Km. This re-
sults in a kcat/Km that is nearly comparable to that of wild-type.
Changing aArg-11 to an alanine results in an enzyme with no
detectable activity using any of the three substrates. However,
the aR11K CaaD is an active enzyme. Using 1, the kcat for the
aR11K-catalyzed reaction is estimated to be down at least 47-fold,
but an accurate Km value could not be determined. Using 2, the kcat
for the aR11K-catalyzed reaction is down 39-fold and the Km is
up 6.7-fold, resulting in a 264-fold reduction in kcat/Km. Using
6, the kcat for the aR11K-catalyzed reaction is up 2.4-fold and
the Km is up 15-fold, resulting in a 6.4-fold decrease in kcat/Km.
Changing bN39 to an alanine yields an enzyme with very low-
level activity using 1 and 2, precluding the accurate determination
of kinetic parameters for these reactions. However, this mutation
has little effect on the kinetic parameters for the hydratase activity
using 6. The kcat for the bN39A-catalyzed reaction is down 3.5-
fold and the Km is down 2.8-fold, resulting in a nearly comparable
kcat/Km to that of wild-type.
In contrast to the large effect of mutations at positions aArg-8
and aArg-11 on the catalytic efﬁciency of CaaD, the mutation of
aPhe-39 to either a threonine or an alanine has less drastic effects
on kcat and Km. Using 1, the kcat for the aF39A-catalyzed reaction is
down 8.3-fold and the Km is down 1.5-fold, resulting in a 5.5-
fold decrease in kcat/Km. For the aF39T mutant, there is a 1.9-fold
decrease in kcat and a 3.1-fold increase in Km using 1. As a result,
the kcat/Km is reduced5.7-fold. Using 2, the kcat for the aF39A-cat-
alyzed reaction is down 11.6-fold and the Km is down 2-fold,
resulting in a 5.8-fold decrease in kcat/Km. For the aF39T mutant,
there is a 2.5-fold decrease in kcat and a 1.2-fold increase in Km
using 2. As a result, the kcat/Km is reduced 3.1-fold. Using 6, the
kcat for the aF39A-catalyzed reaction is down 3.5-fold and the
Km is down 4.4-fold, resulting in a nearly comparable kcat/Km to
that of wild-type. For the aF39T mutant, there is a 2.3-fold de-
crease in kcat and a 10-fold decrease in Km using 6. As a result,
the kcat/Km is increased 4.2-fold.
Changing aPhe-50 to an alanine has a substantial effect on both
kcat and Km. For the aF50A mutant, there is a 20-fold and a 18.2-
fold decrease in kcat, and a 9-fold and a 4.6-fold increase in Km
using 1 and 2, respectively. As a result, the kcat/Km is reduced176-
fold (using 1) or 87-fold (using 2). Interestingly, the reaction of
the aF50A mutant with 6 follows a biphasic time course, consisting
of an initial burst of acetopyruvate (10) formation (equal to one
equivalent of enzyme) followed by a phase that corresponds to
steady state formation of 10 (data not shown). At ﬁrst glance, this
observation could be indicative that product release is theTable 4
Kinetic parameters for the hydration of 6 by CaaD and the active-site mutants.a
Enzyme kcat (s1) Km (lM) Kcat/Km (M1 s1)
CaaDb 0.7 ± 0.02 110 ± 4 6.4  103
aR8A 0.05 ± 0.01 350 ± 90 1.4  102
aR8K 0.06 ± 0.005 15 ± 2 4.0  103
aR11A <0.01 – –
aR11K 1.7 ± 0.1 1640 ± 140 1.0  103
aF39A 0.2 ± 0.01 25 ± 3 8.0  103
aF39T 0.3 ± 0.01 11 ± 1 2.7  104
bN39A 0.2 ± 0.01 40 ± 6 5.0  103
aF50A –c – –
aF50Y 0.7 ± 0.02 45 ± 3 1.6  104
a The steady-state kinetic parameters were determined in 20 mM sodium phos-
phate buffer (pH 9.0) at 22 C. Errors are standard deviations.
b These kinetic parameters were taken from Wang et al. [7].
c The reaction of aF50A-CaaD with 6 follows a biphasic time course, consisting of
an initial burst of acetopyruvate (10) formation followed by a phase that corre-
sponds to steady state formation of 10. The kinetics and mechanism of this reaction
are under investigation.rate-limiting step in the reaction. The kinetics and mechanism of
the aF50A-catalyzed hydration of 6 are under investigation.
In contrast to the decreased catalytic activity of the aF50A mu-
tant, changing aPhe-50 to a tyrosine has a positive effect on kcat.
For the aF50Y mutant, there are 2.5-fold and 2.9-fold increases
in kcat, and 3.9-fold and 3.2-fold increases in Km, using 1 and 2,
respectively. As a result, the kcat/Km is reduced slightly (1.5-fold
using 1 and 1.1-fold using 2). Using 6, the aF50Y mutation has
no effect on kcat and only little effect on Km (2.4-fold decrease).
This results in a 2.4-fold increase in kcat/Km.3.4. pH dependence of the kinetic parameters of aF50A
The pH dependences of kcat and kcat/Km for the aF50A-catalyzed
hydration of 2 were determined in 20 mM sodium phosphate buf-
fer over the pH range 6.0–9.1 [10]. The pH dependences of kcat and
kcat/Km are given by the equations:
KcatðpHÞ ¼ kcat=ð1þ ½Hþ=k1 þ k2=½HþÞ ð1Þ
Kcat=kmðpHÞ ¼ kcat=km=ð1þ ½Hþ=k1 þ k2=½HþÞ ð2Þ
where K1 is the ionization constant of the basic group, K2 is the ion-
ization constant of the acidic group, kcat is the kcat of the enzyme in
the single protonated form, and kcat/Km is the kcat/Km of the enzyme
in the single protonated form [24,25].
A plot of logkcat/Km versus pH shows a bell-shaped dependence
with limiting slopes of unity on either side of the pH maximum,
consistent with Eq. (2), indicating that both a basic group and an
acidic group on the enzyme are important for catalysis, where only
the single protonated form of the enzyme is active [24]. The sub-
strate (pKa = 4.6) does not titrate in the pH range studied. A ﬁt of
the pH-dependence of kcat/Km, which follows the ionization of
the free enzyme, to Eq. (2) gives pKa values for the free enzyme
of pK1 = 6.5 ± 0.3 and pK2 = 7.9 ± 0.2 (data not shown). Signiﬁcantly
different values (pK1 = 7.6 ± 0.2 and pK2 = 9.2 ± 0.2) were previ-
ously reported for the wild-type enzyme.
At saturating levels of the substrate 2, the pH dependence of kcat
shows that the pKa of the basic group is undetectable, suggesting it
has decreased below 6.0. This behavior has also been reported for
the wild type CaaD [10], and can be ﬁt by Eq. (1), but in the present
case K1 H+ causing the middle term in the denominator to disap-
pear. A ﬁt of the pH-dependence of kcat, which follows the ioniza-
tion of the enzyme–substrate complex, to the modiﬁed Eq. (1)
yields a pKa value for the enzyme–substrate complex of
pK2 = 7.9 ± 0.1 (data not shown). This value also differs signiﬁ-
cantly from that previously reported for the hydratase activity
for the wild-type enzyme using 2 (pK2 = 9.5 ± 0.1).3.5. In silico docking experiments using 2
In order to provide insight into the kinetic results, docking stud-
ies were carried out with CaaD using 2. The docking experiment
with 2 (Fig. 2) is an extension of a previously published docking
study [12]. This study suggested that aGlu-52 might play roles in
both substrate binding and product release in addition to partici-
pating in the chemistry (i.e., activating water for attack). In all crys-
tal structures of CaaD, aGlu-52 is observed in two positions [9,11].
In one position, the carboxylate moiety is rotated out of the active
site (PDB entry 3EJ3). In the other position, the carboxylate moiety
points directly into the active site (PDB entry 1S0Y). Rotating be-
tween these two positions could play a role in product release
and, as such, possibly limit the rate of turnover. The results of
the docking studies with 2 also show the two positions. The two
best predicted scores place the carboxylate moiety (of aGlu-52)
out of, or into the active site (Fig. 2A and B). In the crystal
Fig. 2. The top two poses observed in the docking studies of CaaD with 2 (green
stick). (A) The ‘‘open conformation’’ pose where the carboxylate group of aGlu-52
points out of the active site and increases the active site volume. (B) In a second
pose, the carboxylate group of aGlu-52 is positioned to activate a water molecule.
In both poses, the carboxylate group is within hydrogen bond distance of bAsn-39
(shown by dotted lines). The open conformation pose has a slightly better docking
score than the other pose. The Figure was created with PyMol [20].
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of aGlu-52. Regardless of the position of aGlu-52 (out of, or into
the active site), the carboxylate moiety of aGlu-52 remains withinFig. 3. The docking of 2 (blue line) in the in silico aR8K mutant of CaaD. The
interaction of the C1 carboxylate group of 2 with aArg-11 is shown in the mutant.
This docking pose moves C3 of 2 away from aGlu-52, possibly leading to the
observed greatly reduced activity of aR8K mutant (Table 3). For comparison, the
docking pose for 2 (green line) in CaaD is shown (from Fig. 2B) [12]. The C-3
positions of 2 are shown by the arrows. The Figure was created with PyMol [20].hydrogen bonding distance of the amide moiety of bAsn-39 (dotted
lines in Fig. 2A and B). The bN39A mutant of CaaD eliminates the
interaction, which is consistent with the signiﬁcantly reduced
activity for the trans-3-haloacrylates (even though bAsn-39 is more
than 5 Å away from the prolyl nitrogen of Pro-1 and C3 of 2).
Docking studies were also carried out with the individual in sil-
ico aR8K and aR11K mutants of CaaD and 2 (Figs. 3 and 4). The re-
sults provide a possible explanation for the kinetic data collected
for the aR8K and aR11K mutants of CaaD. When 2 is docked into
the aR8K mutant of CaaD, it is pulled toward the remaining
aArg-11 residue (Fig. 3), moving the C3 carbon away from the pro-
posed site of water attack (near aGlu-52) by about 1.2 Å. Moreover,
the lysyl amino group in the aK8 residue is never observed in a po-
sition where it can form an ion-pair or salt bridge with the carbox-
ylate moiety of 2. However, when 2 is docked into the aR11K
mutant of CaaD, 2 remains in the same position (within error) as
that observed in CaaD (Fig. 4). Similar to the results for the aR8K
mutant, the docking routines never place the lysyl amino group
of the aK11 residue within bonding distance of the carboxylate
moiety such that it can form an ion-pair or salt bridge. It appears
that the guanidinium moiety of aArg-8 is more important than
that of aArg-11 in positioning 2 for the proposed chemistry. The
experimental kinetic data agree with the docking results showing
that the aR11K mutant maintains 26% relative speciﬁc activity
while the aR8K mutant yields no detectable activity.
3.6. In silico docking experiments using 6
Docking studies were also carried out with CaaD and 6, as well
as two mutants of CaaD (aR11K and aF50A). Docking 6 into the ac-
tive site of CaaD predicts a similar binding orientation to that ob-
served for 2. However, there are two equivalent predicted
binding orientations for 6 (equivalent based on docking scores),
both showing ﬁve hydrogen bonds to 6: two to each of the active
site arginines (aArg-8 and aArg-11) and one to the backbone
amide nitrogen of aArg-8 (Fig. 5A and B). Both place the C4 of 6
in the same general location as the C3 group of 2 (proximal to
aGlu-52). The major difference between the two orientations is
the potential hydrogen bonding partners of the C2 carbonyl group
of 6. One orientation places the C2 carbonyl group facing the back
of the pocket where it can hydrogen bond to the backbone amide of
aArg-8 (Fig. 5A). The second binding orientation places the C2
carbonyl group facing the front of the pocket with a predictedFig. 4. The docking of 2 (pink line) in the in silico aR11K mutant of CaaD. The
binding pose is comparable to that observed for wild type with 2 (green line) (from
Fig. 2B) [12]. The comparable binding poses might be partially responsible for the
observation that the aR11K mutant of CaaD shows activity with 2, although
reduced relative to the wild type (Table 3). The C-3 positions of 2 are shown by the
arrows. The Figure was prepared using PyMOL [20].
Fig. 5. The two equivalent docking poses for 6 (teal stick) in the active site of CaaD.
(A) In this pose, ﬁve hydrogen bonds are shown between the C1 carboxylate and the
C2 carbonyl group of 6 and CaaD: two hydrogen bonds are shown to each of the two
arginines (aArg-8 and aArg-11) and one hydrogen bond is shown between the C2
carbonyl group and the backbone amide nitrogen of aArg-8. (B) The second pose
shows the same hydrogen bonds but the C2 carbonyl group interacts with the
guanidinium group of aArg-8. The Figure was prepared using PyMOL [20].
Fig. 6. Compound 6 (salmon stick) docked in the aF50A mutant of CaaD modeled in
silico. The predicted cavities in the mutant are shown in salmon transparent
shading. The cavity behind aAla-50 forms a tunnel to the interior of the enzyme.
This space is occupied by Phe-50 in the wild-type enzyme. The docking routine
twists 6 90 from the position shown in Fig. 5A, burying C5, C4, and C3 into the
newly formed tunnel. The Figure was prepared using PyMOL [20].
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residual activity observed for the aR8A and aR8K mutants of CaaD
suggests that the ﬁrst binding orientation might be preferred.
Polarization of the unsaturated system through the C2 carbonyl
group (drawing electron density away from C4) is thought to be
important for the reactivity of 6. In the ﬁrst orientation, the addi-
tional hydrogen bonding interaction is maintained with the back-
bone amide of the residue at position 8 (Arg, Ala, or Lys).
The docking results of 6 with the in silico aR11K mutant of
CaaD show no qualitative difference in the location of 6 between
wild type and the aR11K mutant. However, the aR11K mutant of
CaaD is predicted to have a higher free energy of binding, but not
high enough to account for the difference in Km (10-fold increase
in Table 4 vs. a predicted 2-fold increase, as calculated by the
DDG of binding). Although the Km is probably higher for the
aR11K mutant of CaaD, the one reported in Table 4 might be an
artifact of non-saturating conditions.
The docking results of 6with the in silico aF50Amutant of CaaD
illustrates the importance of a bulky side chain group in this posi-
tion to maintain the integrity of the active site pocket. When aPhe-
50 is changed to an alanine residue (in silico), the pocket volume
increases dramatically and a tunnel forms that leads all the way
into the core of the trimer. This extra space is utilized by the dock-
ing routine, which attempts to bury and twist 6 into the newly
available space (Fig. 6). This orientation positions the C4 carbonof 6 a signiﬁcant distance away from the aGlu-52 residue. (The
docking results include orientations comparable to that observed
for the wild type, but they have lower docking scores.) The docking
results of 2with the in silico aF50A mutant of CaaD show a similar
orientation to that observed for 6 (not shown), which could ac-
count for the diminished activity.
4. Discussion
The current working hypothesis for the mechanism of CaaD
(Scheme 3) is based on the cumulative results of sequence analysis
[1], studies using intermediate analogues as well as reversible and
irreversible inhibitors [2,7], site-directed mutagenesis [1,7,9,10],
NMR experiments [10], pre-steady-state kinetic analysis [12], and
crystallographic studies [9,11]. The importance of bPro-1 and
aArg-11 in the hydrolytic dehalogenation of 1 and 2 was initially
established by sequence analysis and site-directed mutagenesis
[1]. The same study determined that the aR11K mutant partially
restores activity and that the aF39A mutant slows the reaction,
such that aPhe-39 is not essential for activity [1]. The bulk of the
experimental evidence supporting the mechanism came from inhi-
bition as well as NMR and crystallographic studies [7,9,10]. These
studies identiﬁed the promiscuous hydratase activity of CaaD
(i.e., 6 to 10 in Scheme 2A) and the irreversible inhibition of CaaD
by 7 and 8 (Scheme 2B) [7]. The results led to the crystal structure
of the inactivated CaaD, which identiﬁed aArg-8 and aGlu-52 as
the two additional players in the mechanism [9]. Subsequent
site-directed mutagenesis conﬁrmed their importance. In addition
to the position of aGlu-52 in the crystal structure, a hydrogen bond
was observed between aGlu-52 and the backbone carbonyl group
of bIle-37. This observation indicated that side chain of aGlu-52 is
a free acid, which is attributed to the abstraction of a proton from
water to produce the inactivating species (either acyl halide or ke-
tene in Scheme 2B). Hence, aGlu-52 is proposed to function as the
water-activating base. The NMR studies determined a pKa of 9.3 for
bPro-1, suggesting it can be a general acid catalyst and provide a
proton at C-2 [10]. Finally, CaaD shows a robust phenylpyruvate
tautomerase activity, converting phenylenolpyruvate (11, Scheme
4) to phenylpyruvate (12). This observation is consistent with an
enol intermediate (4, Scheme 3 route B) in the reaction, although
a halohydrin intermediate cannot be ruled out [2].
Scheme 4.
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more recent structure of the enzyme in a complex with acetate
(from the precipitant buffer) [11] prompted an examination of
the roles of bAsn-39, aPhe-39, and aPhe-50 in the dehalogenation
mechanism as well as a more extensive analysis of the roles of
aArg-8 and aArg-11. bAsn-39, aArg-8, and aArg-11 are absolutely
essential for activity (although the aR11Kmutant is partially active
using 2). aPhe-50 is important for activity, but not as critical as
bAsn-39, aArg-8, and aArg-11. aPhe-39 is the least critical residue
in this group, as previously reported [1].
The crystal structure of CaaD (where acetate is the ligand)
shows a hydrogen bond between the amide side chain of bAsn-
39 and the carboxylic acid side chain of aGlu-52 [11]. An overlay
of multiple active sites from multiple structures shows the side
chain of aGlu-52 in two conformations (out of, and into the active
site, Fig. 2A and B) [9,11]. However, the hydrogen bond between
the side chains of bAsn-39 and aGlu-52 is maintained. These
observations prompted the suggestion that bAsn-39 performs a
critical role in switching aGlu-52 between conformations where
it activates water in one conformation and enables the release of
product in the other conformation [11,12]. Switching between con-
formations could also facilitate the movement of water molecules
in and out of the active site for the dehalogenation reaction [11].
The switch between conformations might be the unknown par-
tially rate limiting step, identiﬁed by a recent pre-steady state ki-
netic analysis of the reaction [12].
Like bAsn-39, aArg-8 and aArg-11 are critical for dehalogen-
ation activity. The combined modeling and mutagenesis results
provide two new pieces of information. First, the guanidinium
group of aArg-8 is more important for activity than that of aArg-
11 because it positions C-3 of substrate for attack by water. Dock-
ing 2 into the active site of the aR8K mutant moves C3 away from
the site of water attack (1.2 Å) toward the remaining aArg-11
(Fig. 3). Second, although the aR11K mutant partially restores
activity, the side chain of lysine seems to be too ﬂexible for efﬁ-
cient catalysis. The modeling studies suggest the amino group is
not able to interact with the substrate’s C1 carboxylate group in
the aR8K or aR11K mutants.SchemeaPhe-50 is important for activity, but not as important as bAsn-
39, aArg-8, and aArg-11. This residue likely maintains the struc-
tural integrity of the active site, and the loss of the phenyl side
chain has signiﬁcant conseqeunces for activity and the pKa values
of active site residues. This might be due to a combination of the
newly created space and the breech of the active site wall. It is
interesting to note that replacing aPhe-50 with a tyrosine results
in a more active dehalogenase, mostly due to the increase in kcat.
The basis for the increased activity is not known. aPhe-39 is less
important for dehalogenation activity although it along with bIle-
37, aLeu-57, and aPhe-50 comprises the halide-binding pocket.
Evidently, aPhe-39 is not an important component of this pocket
or the pocket is not an important part of the catalytic strategy.
2-Oxo-3-pentynoate (6) has served as a highly informative
mechanistic probe of tautomerase superfamily members. It was
ﬁrst synthesized and used as an active-site-directed irreversible
inhibitor of 4-oxalocrotonate tautomerase (4-OT) [14,26]. The crys-
tal structure of the inactivated enzyme identiﬁed the active site
groups involved in inactivation and suggested a mechanism for
inactivation as well as the biological reaction [26]. Subsequently,
the acetylene compound was used as a probe of the CaaD-cata-
lyzed reaction as well as four additional reactions, those catalyzed
by cis-3-chloroacrylic acid dehalogenase (cis-CaaD) [27], malonate
semialdehyde decarboxylase (MSAD) [28], and two cis-CaaD homo-
logues, one from Corynebacterium glutamicum designated Cg10062
[29], and one from Mycobacterium smegmatis designated MsCCH2
[30]. cis-CaaD, MASD and Cg10062 convert 6 to 10, whereas
MsCCH2 catalyzes a hydration reaction at low pH, but is inacti-
vated at higher pH (vide infra). These different reactions are attrib-
uted to the different pKa values of Pro-1. The hydration reaction
predominates when Pro-1 is cationic and has a higher pKa (CaaD,
cis-CaaD, MSAD, MsCCH2 below its pKa), whereas inactivation is
the primary reaction when Pro-1 is neutral due to a lower pKa
(4-OT and MsCCH2 above its pKa).
The mechanism for the enzyme-catalyzed conversions of 6 to
10 has not been examined in detail, but has always been thought
to involve the Michael addition of water to 6 (Scheme 5) [27–
30]. In this mechanism for the CaaD-catalyzed reaction, aGlu-52
activates a water molecule for nucleophilic attack at C-4 of 6 while
aArg-8 and aArg-11 polarize the carbonyl oxygen and assist in
binding of the carboxylate group. Speciﬁc roles for aArg-8 and
aArg-11 in the mechanism have not been assigned. bPro-1 pro-
vides a proton at C-3 to complete the Michael addition of water.
(The ketonization of 13 to 10 in Scheme 5 could be an enzyme-
catalyzed process or result from a non-enzymatic rearrangement.)5.
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further insight into the hydration reaction. Both aArg-11 and
aPhe-50 are critical for hydratase activity. In contrast to the
dehalogenation reaction, changing bAsn-39 to an alanine has little
effect on the hydration reaction. Like the dehalogenation reaction,
changing aPhe-39 has little effect on the hydration reaction. Mod-
eling suggests that aArg-11 and Arg-8 are important for binding
(via the C1 carboxylate group) and that the backbone amide of
aArg-8 is important for polarization of the a,b-unsaturated system
(via the C2 carbonyl group). These observations suggest that the
positioning of 6 in the active site in the correct (or a fortuituous)
orientation for water addition might be more important than acti-
vating water or activating the substrate for a reaction.
The behavior of the cis-CaaD homologue designated MsCCH2
with 6 might explain, at least in part, the behavior of the aF50A-
catalyzed reaction with 6. Baas et al. reported that incubation of
MsCCH2 with 6 results in the formation of 10 as well as the inac-
tivation of the enzyme by covalent modiﬁcation of Pro-1 [30].
Moreover, the partitioning of 6 between these two processes is
pH dependent. At pH 6.5, the enzyme is predominantly a hydratase
(reﬂecting a cationic Pro-1). At pH 8.5, the enzyme is inactivated
(reﬂecting a neutral Pro-1). At pH 7.3–7.5, the enzyme partitions
between hydration and inactivation.
The mechanism of the aF50A-catalyzed reaction with 6 has not
been examined in detail. However, the removal of the side chain of
aPhe-50 has serious consequences for the active site, as evidenced
by the sharp decrease of the pKa values for both the base and acid
catalysts (to 6.5 from 7.6 and 7.9 from 9.2, respectively). The obser-
vation that there is a burst of production of 10 followed by its stea-
dy state production might involve a partitioning between these
two processes, or some other process. Another possibility is that
product release is now rate-limiting, as is observed with the
CaaD-catalyzed turnover of 2 [12]. The kinetics and mechanism
of the aF50A-catalyzed reaction with 6 are under investigation.
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